Skip to content

Medical emergency? What to do

U.S. OKs heart failure warning on diabetes drugs

3-RXPublished August 17, 20073 min read

Key points

  • Diabetes drugs made by GlaxoSmithKline Plc and Takeda Pharmaceutical Co Ltd will carry new, stronger warnings saying they may or cause or worsen heart failure, U.S. health officials said on Tuesday.
  • Congestive heart failure is a chronic condition in which the heart does not adequately pump blood through the body.
  • The warning finalized on Tuesday says patients with heart failure in either of the two most severe classes should not start taking the drugs, and they are not recommended for patients with heart failure that causes symptoms.
  • The drugs had come with less prominent warnings about heart failure, but FDA officials were concerned that doctors were still prescribing the medicines to patients with the condition.

Diabetes drugs made by GlaxoSmithKline Plc and Takeda Pharmaceutical Co Ltd will carry new, stronger warnings saying they may or cause or worsen heart failure, U.S. health officials said on Tuesday.

The warnings will appear in a "black box" on Glaxo's Avandia, Avandaryl and Avandamet, as well as on Takeda's Actos and Duetact, the Food and Drug Administration said in a statement. A black box is the strongest type of warning in the United States for prescription drugs.

Congestive heart failure is a chronic condition in which the heart does not adequately pump blood through the body. Symptoms may include shortness of breath and excessive, rapid weight gain.

Heart failure is different from a heart attack, which cuts off blood flow and damages the muscle. Heart failure occurs when the heart muscle weakens and can no longer efficiently pump enough blood into the circulatory system. A review of Avandia and a possible increased risk of heart attacks is ongoing, the FDA said.

The warning finalized on Tuesday says patients with heart failure in either of the two most severe classes should not start taking the drugs, and they are not recommended for patients with heart failure that causes symptoms.

If patients develop heart failure after they start taking the medicines, doctors should try to manage the symptoms and use of the drugs "should be reconsidered," the FDA said.

The drugs had come with less prominent warnings about heart failure, but FDA officials were concerned that doctors were still prescribing the medicines to patients with the condition.

The agency said it had received reports of patients with heart failure symptoms who were continued on the drugs and died.

"This new boxed warning addresses FDA's concerns that despite the warnings and information already listed on the drug labels, these drugs are still being prescribed to patients without careful monitoring for signs of heart failure," Dr. Steven Galson, director of the agency's Center for Drug Evaluation and Research, said in a statement.

The FDA disclosed in June that it had asked Glaxo and Takeda to add a stronger heart failure warning to the medicines.

Chris Viehbacher, Glaxo's president of U.S. pharmaceuticals, said doctors have known about the heart failure issue.

"I don't, at this stage, think we're going to see a significant impact on prescribing in terms of dollar value," Viehbacher told reporters on a conference call.

A Takeda spokesman could not immediately be reached for comment.

Sales of Avandia, which were $3 billion last year, have been hurt recently by questions about whether the drug raises the chances of having a heart attack. An advisory panel concluded in July that Avandia did carry that risk and urged a new warning on the drug.

Avandia is known generically as rosiglitazone. Avandamet combines rosiglitazone with the drug metformin, while Avandryl pairs rosiglitazone with glimepiride.

The generic name for Actos is pioglitazone. Duetact is a combination of pioglitazone and glimepiride.

Avandia and Actos are so-called thiazolidinediones that were designed to make the body more sensitive to insulin, a hormone the body needs to convert sugar into energy.

The content on this site is for information only and is not a substitute for professional medical advice, diagnosis or treatment. Drug information pages are an archive and may be out of date: always follow your prescriber, your pharmacist and the current product label. In an emergency, call 911.

Filed underDiabetesHeart

Keep reading

Heart

Comic Gallagher suffers second heart attack

Just days after being released from treatment following a heart attack and a medically induced coma, comedian Gallagher suffered a second heart attack Sunday. His rep confirms to E! News that the 65-year-old funnyman…

1 min read

When to get help

Reading is for later. These need care now.

Call 911 or go to an emergency department if you or someone with you has any of these:

  • Chest pain or pressureEspecially with breathlessness, sweating or pain in the arm, jaw or back. It can be a heart attack.
  • Face drooping, arm weakness, slurred speechSigns of a stroke. Note the time they started: treatment works best within hours.
  • Severe trouble breathingIncluding a severe allergic reaction with swelling of the lips, tongue or throat.
  • Thoughts of suicideCall or text 988 (Suicide & Crisis Lifeline, US) any time, day or night.

Outside the US, call your local emergency number.

See a doctor within days

  1. 01A new lump, or a sore that does not healMost lumps are harmless, but anything that grows or lasts more than a few weeks should be checked.
  2. 02Unexplained weight loss or lasting fatigueLosing weight without trying, or tiredness that does not lift, can have many causes worth finding.
  3. 03A new medicine and new symptomsSide effects and interactions are common. Ask your pharmacist or prescriber before you stop anything.

General guidance only. If you are unsure how urgent a symptom is, call your doctor or a nurse advice line.